No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomized, double-blind, placebo-controlled trial

John Bartlett

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.